Jean Gugenheim
French Institute of Health and Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jean Gugenheim.
Journal of Hepatology | 2017
S. Patouraux; Déborah Rousseau; Stéphanie Bonnafous; Cynthia Lebeaupin; Carmelo Luci; Clémence M. Canivet; Anne-Sophie Schneck; A. Bertola; Marie-Christine Saint-Paul; Antonio Iannelli; Jean Gugenheim; Rodolphe Anty; A. Tran; Béatrice Bailly-Maitre; Philippe Gual
BACKGROUND & AIMSnCluster of differentiation (CD)44 regulates adipose tissue inflammation in obesity and hepatic leukocyte recruitment in a lithogenic context. However, its role in hepatic inflammation in a mouse model of steatohepatitis and its relevance in humans have not yet been investigated. We aimed to evaluated the contribution of CD44 to non-alcoholic steatohepatitis (NASH) development and liver injury in mouse models and in patients at various stages of non-alcoholic fatty liver disease (NAFLD) progression.nnnMETHODSnThe role of CD44 was evaluated in CD44-/- mice and after injections of an αCD44 antibody in wild-type mice challenged with a methionine- and choline-deficient diet (MCDD). In obese patients, hepatic CD44 (n=30 and 5 NASH patients with a second liver biopsy after bariatric surgery) and serum sCD44 (n=64) were evaluated.nnnRESULTSnLiver inflammation (including inflammatory foci number, macrophage and neutrophil infiltration and CCL2/CCR2 levels), liver injury and fibrosis strongly decreased in CD44-/- mice compared to wild-type mice on MCDD. CD44 deficiency enhanced the M2 polarization and strongly decreased the activation of macrophages by lipopolysaccharide (LPS), hepatocyte damage-associated molecular patterns (DAMPs) and saturated fatty acids. Neutralization of CD44 in mice with steatohepatitis strongly decreased the macrophage infiltration and chemokine ligand (CCL)2 expression with a partial correction of liver inflammation and injury. In obese patients, hepatic CD44 was strongly upregulated in NASH patients (p=0.0008) and correlated with NAFLD activity score (NAS) (p=0.001), ballooning (p=0.003), alanine transaminase (p=0.005) and hepatic CCL2 (p<0.001) and macrophage marker CD68 (p<0.001) expression. Correction of NASH was associated with a strong decrease in liver CD44+ cells. Finally, the soluble form of CD44 increased with severe steatosis (p=0.0005) and NASH (p=0.007).nnnCONCLUSIONnHuman and experimental data suggest that CD44 is a marker and key player of hepatic inflammation and its targeting partially corrects NASH.nnnLAY SUMMARYnHuman and experimental data suggest that CD44, a cellular protein mainly expressed in immune cells, is a marker and key player of non-alcoholic steatohepatitis (NASH). Indeed, CD44 enhances the non-alcoholic fatty liver (NAFL) (hepatic steatosis) to NASH progression by regulating hepatic macrophage polarization (pro-inflammatory phenotype) and infiltration (macrophage motility and the MCP1/CCL2/CCR2 system). Targeting CD44 partially corrects NASH, making it a potential therapeutic strategy.
Diabetes & Metabolism | 2012
T. Ciucci; A. Bertola; Déborah Rousseau; Virginie Bourlier; Carine Duffaut; Stéphanie Bonnafous; C. Blin-Wakkach; Rodolphe Anty; Antonio Iannelli; Jean Gugenheim; A. Tran; Anne Bouloumié; A. Wakkach; Philippe Gual
Introduction La regulation des cellules T dans le tissu adipeux constitue un lien important entre l’inflammation et l’insulino-resistance. Nous avons recherche les cellules presentatrices d’antigenes dans le tissu adipeux des souris et patients obeses en fonction de l’insulino-resistance. Patients et methodes Les cellules dendritiques ont ete etudiees dans le tissu adipeux de souris minces, obeses (HFD), Rag1–/–, de 20 patients avec des IMC allant de 19,5 a 38xa0kg/m2, ainsi que des patients obeses morbides sans (nxa0=xa010) ou avec un diabete de type 2 (nxa0=xa0110) par des approches de cytometrie en flux et PCR quantitative Resultats Chez la souris mince, la presence des CDs residantes (CD11chighF4/80neg) est detectee dans le tissu adipeux epididymaire. Chez des souris deficientes en cellules T, le transfert adoptif de cellules T naive specifique a l’ovalbumine induit majoritairement une reponse de type Th1 en reponse a l’ovalbumine dans le tissu adipeux. Dans les souris et patients obeses, les CDs (CD11c+CD1c+ chez l’homme et CD11chighF4/80lowCX3CR1pos chez la souris) sont majoritairement accumulees dans le tissu adipeux. Les CDs CD11chighF4/80low isolees chez les souris obeses induisent, ex-vivo, la polarisation des cellules T naives en cellules Th17. Dans une cohorte de 20 patients, le nombre de cellules CD1c+CD11c+ par g de tissu adipeux sous-cutanes est correle a IMC (rsxa0=xa010,4947; Pxa0 Conclusion Nous montrons, pour la premiere fois, la presence et l’accumulation des CDs dans le tissu adipeux en fonction de l’obesite et de l’insulino-resistance chez la souris et les patients. Ces cellules dendritiques sont fonctionnelles et pourraient favoriser la polarisation des cellules T en Th1 et Th17 dans le tissu adipeux inflamme.
Hepatology | 1986
Didier Houssin; Blanche Bellon; Marie‐Dominique Brunaud; Jean Gugenheim; Abdellatif Settaf; Francesco Meriggi; Jean Emond
Hepatology | 1997
Véronique Barbu; Anne-Marie Bonnand; Sophie Hillaire; Thierry Coste; Olivier Chazouillères; Jean Gugenheim; Eveline Boucher; Raoul Poupon; R. Poupon
Hépato-Gastro & Oncologie Digestive | 2005
Thierry Piche; Antonio Iannelli; Moncef Dahman; Faredj Cherikh; Jean-François Demarquay; Xavier Hébuterne; A. Tran; Jean Gugenheim
Journal of Hepatology | 2015
Rodolphe Anty; Yang-Lin Liu; Antonio Iannelli; S. Patouraux; C.M. Canivet; Imed Ben-Amor; A.-S. Schneck; Marie-Christine Saint-Paul; Jean Gugenheim; Christopher P. Day; Ann K. Daly; A. Tran; Philippe Gual; Quentin M. Anstee
Journal of Obesity and Chronic Diseases | 2017
Francesco Martini; Rodolphe Anty; Anne-Sophie Schneck; Reza Tavana; Stéphanie Patouraux; Jean Gugenheim; Philippe Gual; A. Tran; Antonio Iannelli
La Lettre de l'hépato-gastroentérologue | 2010
Antonio Iannelli; Anne-Sophie Schneck; Rodolphe Anty; Jean Gugenheim
La Lettre de l'hépato-gastroentérologue | 2010
Antonio Iannelli; Anne-Sophie Schneck; Rodolphe Anty; Raffaella Dainese; Jean Gugenheim
Soins | 2008
Olga Castano; Jean Gugenheim; Véronique Rognone; Thierry Yandza